A vaccine is not too far for COVID-19

Shailesh Kumar Patel; Mamta Pathak; Ruchi Tiwari; Mohd Iqbal Yatoo; Yashpal Singh Malik; Ranjit Sah; Ali A. Rabaan; Khan Sharun; Kuldeep Dhama; D. Katterine Bonilla-Aldana; Alfonso J. Rodriguez-Morales

doi:10.3855/jidc.12744

A vaccine is not too far for COVID-19

Shailesh Kumar Patel
, Mamta Pathak
, Ruchi Tiwari
, Mohd Iqbal Yatoo
, Yashpal Singh Malik
, Ranjit Sah
, Ali A. Rabaan
, Khan Sharun
, Kuldeep Dhama
, D. Katterine Bonilla-Aldana
, Alfonso J. Rodriguez-Morales

Producción científica: Artículo Científico › Artículo original › revisión exhaustiva

31 Citas (Scopus)

Resumen

Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.

Idioma original	Inglés estadounidense
Páginas (desde-hasta)	450-453
-	4
Publicación	Journal of Infection in Developing Countries
Volumen	14
N.º	5
DOI	https://doi.org/10.3855/jidc.12744
Estado	Indizado - 31 may. 2020
Publicado de forma externa	Sí

Nota bibliográfica

Publisher Copyright:
Copyright © 2020 Patel et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.3855/jidc.12744

Citar esto

@article{5078631ea01545bf887e788547346cad,

title = "A vaccine is not too far for COVID-19",

abstract = "Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.",

keywords = "COVID-19, SARS-CoV-2, Vaccines",

author = "Patel, \{Shailesh Kumar\} and Mamta Pathak and Ruchi Tiwari and Yatoo, \{Mohd Iqbal\} and Malik, \{Yashpal Singh\} and Ranjit Sah and Rabaan, \{Ali A.\} and Khan Sharun and Kuldeep Dhama and Bonilla-Aldana, \{D. Katterine\} and Rodriguez-Morales, \{Alfonso J.\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2020 Patel et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",

year = "2020",

month = may,

day = "31",

doi = "10.3855/jidc.12744",

language = "American English",

volume = "14",

pages = "450--453",

journal = "Journal of Infection in Developing Countries",

issn = "2036-6590",

publisher = "Journal of Infection in Developing Countries",

number = "5",

}

TY - JOUR

T1 - A vaccine is not too far for COVID-19

AU - Patel, Shailesh Kumar

AU - Pathak, Mamta

AU - Tiwari, Ruchi

AU - Yatoo, Mohd Iqbal

AU - Malik, Yashpal Singh

AU - Sah, Ranjit

AU - Rabaan, Ali A.

AU - Sharun, Khan

AU - Dhama, Kuldeep

AU - Bonilla-Aldana, D. Katterine

AU - Rodriguez-Morales, Alfonso J.

N1 - Publisher Copyright: Copyright © 2020 Patel et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2020/5/31

Y1 - 2020/5/31

N2 - Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.

AB - Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.

KW - COVID-19

KW - SARS-CoV-2

KW - Vaccines

UR - https://www.scopus.com/pages/publications/85086354141

U2 - 10.3855/jidc.12744

DO - 10.3855/jidc.12744

M3 - Original Article

C2 - 32525830

AN - SCOPUS:85086354141

SN - 2036-6590

VL - 14

SP - 450

EP - 453

JO - Journal of Infection in Developing Countries

JF - Journal of Infection in Developing Countries

IS - 5

ER -

A vaccine is not too far for COVID-19

Resumen

Nota bibliográfica

ODS de las Naciones Unidas

Acceder al documento

Huella

Citar esto